There is no official "golden dose" of Mounjaro. The phrase is patient shorthand, and it means two different things.
The original meaning is the liquid left in a KwikPen after the four prescribed doses, which is not a usable dose and should not be extracted.
The newer meaning is a personal sweet spot, the dose where appetite control feels strongest and side effects stay manageable.
The licensed UK doses run from 2.5mg to a maximum of 15mg once weekly, and the goal is the lowest dose that works well for you, not the highest one you can reach.
If you're about to start Mounjaro, or you're a few weeks in, you have probably come across the phrase "golden dose" in a Facebook group or on TikTok.
It is used with enough confidence to sound like a real clinical term.
It isn't one.
In fact, it may make you feel something like this: Everyone else has found the magic dose, and I haven't, or I'm on the wrong dose and wasting the treatment, or there's a trick I'm missing.
None of that is true.
What is true is that people respond differently to the same dose, and that the schedule is designed to find your response rather than to rush you to the top of the ladder.
The guide below lays out what exactly is the Mounjaro golden dose, should you try to extract it, and which side effects you might experience while trying to inject the Mounjaro golden dose.
Before you begin: A little bit about OnlineClinic
OnlineClinic has been operating since 2011 and has treated more than 2.1 million patients.
The pharmacy is registered with the General Pharmaceutical Council (GPhC), our prescribers are registered with the General Medical Council (GMC), and the service is regulated by the Care Quality Commission (CQC).
As of August 2026, on Trustpilot, the service rating is 4.6 out of 5 based on 7,010 reviews.
This is the original meaning, and you'll also see it called the "fifth dose" or the "magic fifth dose".
A Mounjaro KwikPen is designed to deliver four fixed weekly doses.
When those four doses have been injected, there is visible liquid left in the injection pen. Videos circulated showing people drawing it out with insulin syringes and treating it as a free extra week of treatment.
That liquid is there by design. It is overfill, used to prime the pen and to make sure each of the four doses delivers its full amount.
It is not a fifth dose.
More recently, people have started using "golden dose" to mean the dose at which everything clicks: Appetite quietens, the food noise settles, weight comes off at a steady rate, and side effects are manageable.
You'll see the same idea described as the sweet spot dose.
This meaning describes something real.
Most people do find a dose where the balance between effect and side effects feels right.
What it gets wrong is the implication that there is one specific number, the same for everybody, waiting to be discovered.
Community discussion often lands on 7.5mg or 10mg, but that reflects where a lot of people happen to settle, not evidence that those doses are better in general.
The National Pharmacy Association has warned about this publicly. Its chairman, Olivier Picard, told The Independent that there is no such thing as a golden dose, and described attempts to extract it as inappropriate.
Eli Lilly's position is the same: An additional complete dose cannot be dialled, and the pen should be discarded after four doses or 30 days after first use.
Please don't do this
Do not open, cut, or draw liquid from a used Mounjaro pen. If you are running short before your next delivery, or the cost is becoming difficult, tell us instead.
A prescriber can look at your dose, your timing, and your options.
Improvising with an unknown quantity of medicine is the one response that adds risk without adding benefit.
Eli Lilly confirmed in March 2026 that the KwikPen has been modified to reduce the medicine left after the final dose, and to make it easier to tell when that final dose has been given.
The modified pen started reaching the UK from April 2026 as earlier stock was used up.
If your pen looks slightly different from your last one, that is why.
The medicine, the strength, the weekly schedule, and the injection technique are all unchanged.
Our guide to injecting Mounjaro covers the technique either way.
Mounjaro (tirzepatide) is licensed in the UK at 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg.
The prescribing information sets out the pattern clearly.
Treatment starts at 2.5mg once weekly. After four weeks, the dose increases to 5mg.
Any further increases are made in 2.5mg steps, with a minimum of four weeks at the current dose before moving up.
The recommended maintenance doses are 5mg, 10mg, and 15mg, and 15mg is the maximum dose - read our guide on Mounjaro dosage schedule to know more.
Three doses are described as maintenance doses. The doses in between (7.5mg and 12.5mg) exist mainly as stepping stones to help you get to the next maintenance level comfortably, although some people do stay on them.
On average, yes, with diminishing returns towards the top of the range.
SURMOUNT-1, published in the New England Journal of Medicine in 2022, followed adults with obesity or overweight for 72 weeks. Here’s what the results showed:
| Weekly dose | Average weight change |
|---|---|
| 5mg | −15.0% |
| 10mg | −19.5% |
| 15mg | −20.9% |
| Placebo | −3.1% |
Two things stand out.
The step up from 5mg to 10mg is large. The step up from 10mg to 15mg is small, around 1.4 percentage points on average, while the side effect burden keeps rising.
That is the clinical reason a prescriber may be content for you to settle at 10mg rather than push to the maximum.
Also read: How long does it take for Mounjaro to work
In SURMOUNT-1, the proportion of people who lost at least a fifth of their body weight was 30% at 5mg, 50% at 10mg, and 57% at 15mg.
For a quarter of body weight or more, the figures were 15.3%, 32.3%, and 36.2%. Compare that with 3.1% and 1.5% respectively on placebo.
Read those numbers the other way round.
Nearly a third of people on the lowest maintenance dose lost more than 20% of their body weight.
More than 40% of people on the highest dose did not.
Two people on the same dose, with similar starting weights, can have genuinely different results, and neither of them has done anything wrong.
So when someone in a group says "10mg is the golden dose", what they are really reporting is that 10mg was their golden dose. That is useful information about them. It says very little about you.
The UK prescribing information frames continuation around the highest dose you tolerate, not the maximum dose that exists.
The formal review point is six months: If someone has not lost at least 5% of their starting body weight after taking the highest tolerated dose, the prescriber reconsiders whether continuing makes sense, weighing the benefits and risks for that individual.
It does not mean everyone must reach 15mg.
It means the dose you can tolerate is the reference point.
If you are losing weight steadily at 5mg or 7.5mg and you feel well, there is no clinical prize for increasing the dose, and moving up brings a predictable increase in side effects.
Where stepping up genuinely helps is when appetite suppression has clearly faded, weight loss has stalled for several weeks, and you are tolerating your current dose comfortably.
That combination is a reasonable trigger for a conversation with your prescriber.
Wanting faster results on its own is not, because faster is not what a higher dose reliably delivers.
The gradual dosage schedule exists for a reason.
Gastrointestinal side effects are the most common reason people struggle with tirzepatide, and they are at their peak around dose increases.
| Effect | 5mg | 10mg | 15mg |
|---|---|---|---|
| Nausea | 24.6% | 33.3% | 31.0% |
| Diarrhoea | 18.7% | 21.2% | 23.0% |
| Vomiting | 8.3% | 10.7% | 12.2% |
| Stopped treatment because of side effects | 4.3% | 7.1% | 6.2% |
Most of these effects were mild to moderate and settled as the body adjusted.
But the pattern is clear enough to plan around: Each step up usually brings a week or two of the early symptoms back.
If you are managing a demanding fortnight at work, it is reasonable to ask your prescriber to time a dose increase differently.
Our week-by-week guide to Mounjaro side effects sets out what to expect at each stage and what helps.
Four weeks is the minimum interval between increases, and there is good reason not to judge a dose before then.
A published analysis of SURMOUNT-1 looked specifically at people who responded late.
Among them, the average time to reach 5% weight loss was around 25 weeks, and 90% had reached it by the end of the 72-week trial. Slow early progress did not predict poor eventual results.
This matters for first-timers in particular, because the first four weeks at 2.5mg are not a therapeutic test.
That dose exists to let your digestive system adapt.
If very little happens on the scale during that month, the schedule is working as designed.
A few flat weeks is normal variation, not a plateau.
Weight moves with fluid, glycogen, salt, bowel transit and, for many women, the menstrual cycle.
Four or more weeks without change is the point at which it is worth investigating.
When loss does genuinely stall, a dose increase is one option among several, and not automatically the first one.
Protein intake, resistance training, everyday movement, sleep and a gradual drift in portion sizes all matter.
Our guide on Mounjaro weight loss plateau explains this in detail.
What is not a good idea is changing your own dose, doubling up after a missed week, or splitting doses differently from your prescription.
Those decisions change your risk of side effects without a matching change in benefit.
Message us through your account if:
You can report any suspected side effect directly through the MHRA Yellow Card scheme, as well as telling us.
Our process is straightforward. From start to finish, this is what happens when you order with us:
Our Mounjaro prices start at £139.99, and every price includes the prescription, the consultation, the packaging, and delivery. There are no hidden fees.
We prescribe Mounjaro for weight management following an online consultation.
Disclaimer
Mounjaro is a prescription-only medicine. Decisions about dose, switching, or stopping are made by a GMC-registered prescriber based on your individual medical history. Weight loss results vary between individuals and no outcome can be guaranteed. The information here is for general guidance and is not a substitute for professional medical advice.
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Reviewed by Dr. Anup Jethwa
Not sure which treatment is right for you?
No obligation · Reviewed by GMC-registered prescribers · CQC regulated